| RS2146919315 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146919339 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2146919800 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2146919819 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146921337 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146921497 |
KDM5C
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2146922561 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2146922620 |
PCNT
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2146922648 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2146930042 |
ZNF526
|
Health Risk |
Pathogenic |
Dentici-Novelli neurodevelopmental syndrome, Dentici-Novelli neurodevelopmental syndrome |
| RS2146932748 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2146933945 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS2146934768 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS2146934832 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146934865 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146936860 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS2146940260 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS2146946828 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146946968 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS2146947108 |
TBCD
|
Health Risk |
Likely pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS2146947345 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146947627 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146948133 |
ERF
|
Health Risk |
Likely pathogenic |
TWIST1-related craniosynostosis, TWIST1-related craniosynostosis |
| RS2146949300 |
ERF
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, TWIST1-related craniosynostosis |
| RS2146949591 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS2146950390 |
ERF
|
Health Risk |
Likely pathogenic |
Lambdoidal craniosynostosis, Lambdoidal craniosynostosis |
| RS2146952114 |
ERF
|
Health Risk |
Pathogenic/Likely pathogenic |
TWIST1-related craniosynostosis, Lambdoidal craniosynostosis |
| RS2146953457 |
SMS
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Snyder type, Syndromic X-linked intellectual disability Snyder type |
| RS2146954029 |
SMS
|
Health Risk |
Likely pathogenic |
— |
| RS2146960176 |
ERF
|
Health Risk |
Conflicting classifications of pathogenicity |
Lambdoidal craniosynostosis, Lambdoidal craniosynostosis |
| RS2146960379 |
SMS
|
Health Risk |
Likely pathogenic |
— |
| RS2146961698 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146966211 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146966216 |
NF2
|
Health Risk |
Likely pathogenic |
SMARCB1-related schwannomatosis, Neurofibromatosis |
| RS2146966294 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146966417 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146966627 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS2146966685 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146966936 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS2146967302 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146968484 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS2146970113 |
OFD1
|
Health Risk |
Pathogenic |
Simpson-Golabi-Behmel syndrome type 2, Simpson-Golabi-Behmel syndrome type 2 |
| RS2146972508 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146974102 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146974183 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146974254 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2146978491 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146978931 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS2146979490 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2146979498 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146979520 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2146979558 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146979567 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146984250 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS2146987638 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2146987683 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146987697 |
PHEX
|
Health Risk |
Likely pathogenic |
Hypophosphatemic rickets, Hypophosphatemic rickets |
| RS2146987767 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146987783 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2146987874 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2146987897 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146987952 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2146989146 |
MBOAT7
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS2146989498 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146989887 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146990314 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146990737 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2146990961 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS2146991528 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146991715 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2146992010 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2146999184 |
GLRA2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2146999591 |
IQSEC2
|
Health Risk |
Likely pathogenic |
— |
| RS2146999877 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2146999914 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147000428 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147000837 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2147000956 |
IQSEC2
|
Health Risk |
Pathogenic |
Undetermined early-onset epileptic encephalopathy, Undetermined early-onset epileptic encephalopathy |
| RS2147001369 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147003883 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147004911 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2147005509 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2147005760 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2147005856 |
TSEN54
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 4, Pontocerebellar hypoplasia type 4 |
| RS2147006012 |
USP9X
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147006202 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS2147006209 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2147006296 |
TSEN54
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 4, Pontocerebellar hypoplasia type 4 |
| RS2147006430 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS2147007005 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2147007205 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS2147007353 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2147007424 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2147007533 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147009482 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147009961 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS2147010150 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2147010188 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2147010401 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2147010427 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |